Identification of candidate predictive and surrogate molecular markers for dasatinib in prostate cancer: rationale for patient selection and efficacy monitoring

Overview of attention for article published in Genome Biology, November 2007

Altmetric Badge

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 76 Dimensions

Readers on

mendeley: 67 Mendeley
citeulike: 1 CiteULike

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

Modulator compounds of drug resistance in epithelial tumor cells

Grant US-9820987-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.